Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF

By /

Disrupted VEGF–VEGFR2 binding, reducing angiogenesis and tumor growth in A549 xenografts.

Leave a Comment

Your email address will not be published. Required fields are marked *

Fucoidan AI Assistant

✕
Hello! I am Fucoidan AI. I provide research-backed info on Fucoidan studies. How can I help you today?
AI is thinking...
Engineered by Syed Ahmar Ali

Looking for High-Purity Fucoidan?

NatureMedic™ Fucoidan is trusted by integrative professionals worldwide.

Learn More at NMfucoidan.com
Scroll to Top

Disclaimer

The information provided on this website is for educational and informational purposes only and is not intended as medical advice. Fucoidan Research does not diagnose, treat, cure, or prevent any disease. Always consult with a qualified healthcare professional before beginning any new supplement regimen, especially if you are currently undergoing medical treatment.